<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects of recombinant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>Necrosis</z:mp> Factor alpha (r-TNF alpha) on polyphosphoinositide metabolism were examined in a Burkitt <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> cell line (Daudi cells) </plain></SENT>
<SENT sid="1" pm="."><plain>After 1 h of in vitro treatment with r-TNF alpha, the incorporation of 32Pi into phosphatidylinositol 4,5-phosphate (PtdInsP2), phosphatidylinositol 4-phosphate (PtdInsP) and phosphatidylinositol (<z:chebi fb="0" ids="16749">PtdIns</z:chebi>) was reduced compared with controls, confirming previous findings observed in other cell lines of a specific <z:chebi fb="0" ids="16749">PtdIns</z:chebi> breakdown following r-TNF alpha treatment </plain></SENT>
<SENT sid="2" pm="."><plain>The novelty of this study is therefore the demonstration of early changes in polyphosphoinositide metabolism during the antiproliferative response elicited by this cytokine in Daudi cells </plain></SENT>
</text></document>